News
Archive
Ventyx Biosciences announces initiation of dosing in a Phase 2a trial of VTX3232 in patients with early Parkinson’s disease
Vascular Therapies completes enrollment in the ACCESS 2 study, a Phase III multinational randomized clinical trial of the Sirolimus Eluting Collagen Implant (Sirogen™) for the surgical creation of arteriovenous fistula for hemodialysis vascular access
Ventyx Biosciences announces results from the Phase 2 trial of VTX958 in participants with moderately to severely active Crohn’s disease
Emporos and InterLink AI Partner, develop only POS-Integrated lighted will-call solution
Phase Four partners with Redwire to expand space propulsion offerings and deliver Hall Effect Thrusters
Primemas selects Achronix embedded FPGA technology for System-on-Chip (SoC) Hub Chiplet platform
Back To News![FUZZY LOGIX NAMED FINALIST FOR THE 2017 TERADATA PARTNER ‘EPIC’ AWARD](https://www.newscienceventures.com/wp-content/uploads/2020/11/fuzzylogix.png)
October 23, 2017
FUZZY LOGIX NAMED FINALIST FOR THE 2017 TERADATA PARTNER ‘EPIC’ AWARD
Fuzzy Logix, a pioneer in in-database analytics, announced that it has been selected as a finalist for the Teradata PARTNERS Epic Awards in the Big Data Intelligence category.
The post FUZZY LOGIX NAMED FINALIST FOR THE 2017 TERADATA PARTNER ‘EPIC’ AWARD appeared first on Fuzzy Logix.